Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Does obesity-induced τ phosphorylation tip the scale toward dementia?

Gendron TF, Zhang YJ, Petrucelli L.

Diabetes. 2013 May;62(5):1365-6. doi: 10.2337/db12-1784. No abstract available.

PMID:
23613550
2.

Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice.

Leboucher A, Laurent C, Fernandez-Gomez FJ, Burnouf S, Troquier L, Eddarkaoui S, Demeyer D, Caillierez R, Zommer N, Vallez E, Bantubungi K, Breton C, Pigny P, Buée-Scherrer V, Staels B, Hamdane M, Tailleux A, Buée L, Blum D.

Diabetes. 2013 May;62(5):1681-8. doi: 10.2337/db12-0866. Epub 2012 Dec 18.

PMID:
23250356
3.

Hyperphosphorylation of tau protein in hippocampus of central insulin-resistant rats is associated with cognitive impairment.

Peng D, Pan X, Cui J, Ren Y, Zhang J.

Cell Physiol Biochem. 2013;32(5):1417-25. doi: 10.1159/000356579. Epub 2013 Nov 28. Erratum in: Cell Physiol Biochem. 2014;33(6):2014.

PMID:
24335173
4.

Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet.

Bhat NR, Thirumangalakudi L.

J Alzheimers Dis. 2013;36(4):781-9. doi: 10.3233/JAD-2012-121030.

PMID:
23703152
5.

Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation.

Kim B, Figueroa-Romero C, Pacut C, Backus C, Feldman EL.

J Biol Chem. 2015 Jul 31;290(31):19146-57. doi: 10.1074/jbc.M115.636852. Epub 2015 Jun 22.

PMID:
26100639
6.

A mouse model to study tau pathology related with tau phosphorylation and assembly.

Engel T, Lucas JJ, Hernández F, Avila J.

J Neurol Sci. 2007 Jun 15;257(1-2):250-4. Epub 2007 Mar 23.

PMID:
17362999
7.

Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.

Milenkovic I, Petrov T, Kovacs GG.

Dement Geriatr Cogn Disord. 2014;38(5-6):375-88. doi: 10.1159/000365548. Epub 2014 Sep 5.

PMID:
25195847
8.

Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.

Koss DJ, Robinson L, Mietelska-Porowska A, Gasiorowska A, Sepčić K, Turk T, Jaspars M, Niewiadomska G, Scott RH, Platt B, Riedel G.

Cell Mol Life Sci. 2015 Dec;72(23):4613-32. doi: 10.1007/s00018-015-1949-4. Epub 2015 Jun 13.

PMID:
26070304
9.

Immunohistochemical analysis of tau phosphorylation and astroglial activation with enhanced leptin receptor expression in diet-induced obesity mouse hippocampus.

Koga S, Kojima A, Kuwabara S, Yoshiyama Y.

Neurosci Lett. 2014 Jun 13;571:11-6. doi: 10.1016/j.neulet.2014.04.028. Epub 2014 Apr 28.

PMID:
24785100
10.

Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in vivo.

Becker K, Freude S, Zemva J, Stöhr O, Krone W, Schubert M.

Neurosci Lett. 2012 May 16;516(2):306-10. doi: 10.1016/j.neulet.2012.04.022. Epub 2012 Apr 12.

PMID:
22521314
11.

Female hippocampus vulnerability to environmental stress, a precipitating factor in Tau aggregation pathology.

Sotiropoulos I, Silva J, Kimura T, Rodrigues AJ, Costa P, Almeida OF, Sousa N, Takashima A.

J Alzheimers Dis. 2015;43(3):763-74. doi: 10.3233/JAD-140693.

PMID:
25159665
12.

Tauopathies and tau oligomers.

Takashima A.

J Alzheimers Dis. 2013;37(3):565-8. doi: 10.3233/JAD-130653. Review.

PMID:
23948895
13.

O-GlcNAc modification and the tauopathies: insights from chemical biology.

Yuzwa SA, Vocadlo DJ.

Curr Alzheimer Res. 2009 Oct;6(5):451-4. Review.

PMID:
19874270
14.

Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats.

Špolcová A, Mikulášková B, Kršková K, Gajdošechová L, Zórad Š, Olszanecki R, Suski M, Bujak-Giżycka B, Železná B, Maletínská L.

BMC Neurosci. 2014 Sep 25;15:111. doi: 10.1186/1471-2202-15-111.

PMID:
25257559
15.

Frontotemporal dementia with tau pathology.

Gasparini L, Terni B, Spillantini MG.

Neurodegener Dis. 2007;4(2-3):236-53. Review.

PMID:
17596718
16.

mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.

Caccamo A, Magrì A, Medina DX, Wisely EV, López-Aranda MF, Silva AJ, Oddo S.

Aging Cell. 2013 Jun;12(3):370-80. doi: 10.1111/acel.12057. Epub 2013 Mar 24.

PMID:
23425014
17.

High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status.

Takalo M, Haapasalo A, Martiskainen H, Kurkinen KM, Koivisto H, Miettinen P, Khandelwal VK, Kemppainen S, Kaminska D, Mäkinen P, Leinonen V, Pihlajamäki J, Soininen H, Laakso M, Tanila H, Hiltunen M.

J Nutr Biochem. 2014 Jun;25(6):634-41. doi: 10.1016/j.jnutbio.2014.02.003. Epub 2014 Mar 12.

PMID:
24746833
18.

RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies.

Gallo JM, Noble W, Martin TR.

Cell Mol Life Sci. 2007 Jul;64(13):1701-14. Review.

PMID:
17453144
19.

Tau phosphorylation and aggregation as a therapeutic target in tauopathies.

Badiola N, Suárez-Calvet M, Lleó A.

CNS Neurol Disord Drug Targets. 2010 Dec;9(6):727-40. Review.

PMID:
20942789
20.

High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice.

Rahman A, Akterin S, Flores-Morales A, Crisby M, Kivipelto M, Schultzberg M, Cedazo-Mínguez A.

FEBS Lett. 2005 Nov 21;579(28):6411-6. Epub 2005 Nov 2.

PMID:
16288750

Supplemental Content

Support Center